COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES

Glucocorticoids (GCs) are often used as an adjuvant therapy to reduce the adverse effects of chemotherapy in breast cancer patients. Moreover, GCs can display pro-proliferative or anti-proliferative effects on BC cells depending on their molecular subtype. In addition, long-term use of GCs can induc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Formato:	Artigo
Idioma:	Russo
Publicado em:	Russian Academy of Sciences, Tomsk National Research Medical Center 2017-12-01
coleção:	Сибирский онкологический журнал
Assuntos:	molecular subtypes of breast cancer glucocorticoids selective activators of glucocorticoid receptor compound a cpda
Acesso em linha:	https://www.siboncoj.ru/jour/article/view/640
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!